Bradbury Daniel's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Jan 8, 2024
- Accession no.
- 0001447362-24-000008
- Filed
- Jan 8, 2024
- Trade date
- Jan 4-5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $475.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bradbury DanielCIK 0001236397 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Common Stock | SSaleDisposed | −5,776 | $20.40F2 | −$117,830.4 | 66,312 | Indirect | |
| Jan 4, 2024 | Common Stock | SSaleDisposed | −6,222 | $20.40F2 | −$126,928.8 | 43,574 | Indirect | |
| Jan 4, 2024 | Common Stock | SSaleDisposed | −6,225 | $20.40F2 | −$126,990 | 43,591 | Indirect | |
| Jan 5, 2024 | Common Stock | SSaleDisposed | −1,617 | $20.36F6 | −$32,922.12 | 64,695 | Indirect | |
| Jan 5, 2024 | Common Stock | SSaleDisposed | −1,741 | $20.36F6 | −$35,446.76 | 41,833 | Indirect | |
| Jan 5, 2024 | Common Stock | SSaleDisposed | −1,742 | $20.36F6 | −$35,467.12 | 41,849 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.23 to $20.83, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $20.05 to $20.62, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.